日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Using Natural Language Processing to Explore Patient Perspectives on AI Avatars in Support Materials for Patients With Breast Cancer: Survey Study

利用自然语言处理技术探索乳腺癌患者对辅助材料中人工智能虚拟形象的看法：一项调查研究

期刊:Journal of Medical Internet Research
影响因子:6
doi:10.2196/70971
Cheese, Eleanor; Bichoo, Raouef Ahmed; Grover, Kartikae; Dumitru, Dorin; Zenonos, Alexandros; Groark, Joanne; Gibson, Douglas; Pope, Rebecca
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study

贝利木单抗皮下注射联合一个疗程利妥昔单抗序贯治疗系统性红斑狼疮患者的疗效和安全性：一项3期随机、安慰剂对照的BLISS-BELIEVE研究

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard-2024-225686
Aranow, Cynthia; Allaart, Cornelia F; Amoura, Zahir; Bruce, Ian N; Cagnoli, Patricia C; Chatham, Walter W; Clark, Kenneth L; Furie, Richard; Groark, James; Urowitz, Murray B; van Vollenhoven, Ronald; Daniels, Mark; Fox, Norma Lynn; Gregan, Yun Irene; Henderson, Robert B; van Maurik, André; Ocran-Appiah, Josephine C; Oldham, Mary; Roth, David A; Shanahan, Don; Tak, Paul P; Teng, Yk Onno
红斑狼疮
免疫/内分泌
发表日期：2024
文献求助 收藏

Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus

一项针对患有系统性红斑狼疮的黑人非洲裔患者的贝利木单抗疗效和安全性的 III/IV 期随机 52 周研究

期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.41900
Ginzler, Ellen; Guedes Barbosa, Luiz Sergio; D'Cruz, David; Furie, Richard; Maksimowicz-McKinnon, Kathleen; Oates, James; Santiago, Mittermayer Barreto; Saxena, Amit; Sheikh, Saira; Bass, Damon L; Burriss, Susan W; Gilbride, Jennifer A; Groark, James G; Miller, Michelle; Pierce, Amy; Roth, David A; Ji, Beulah
红斑狼疮
免疫/内分泌
发表日期：2022
文献求助 收藏

Novel attributes of cell-free plasma mitochondrial DNA in traumatic injury

创伤性损伤中游离血浆线粒体DNA的新特性

期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.1055
Daly, Grant T; Pastukh, Viktor M; Tan, Yong B; Francis, C Michael; Aggen, C Zack; Groark, S Chris; Edwards, Carson; Mulekar, Madhuri S; Hamo, Mohammad; Simmons, Jon D; Kutcher, Matthew E; Hartsell, Emily M; Dinwiddie, Darrell L; Turpin, Zachary M; Bass, Hank W; Roberts, Justin T; Gillespie, Mark N; Langley, Raymond J
线粒体
发表日期：2022
文献求助 收藏

Case report: Improving quality of care in Kazakhstan institutions

案例报告：改善哈萨克斯坦医疗机构的护理质量

期刊:Frontiers in Psychology
影响因子:2.9
doi:10.3389/fpsyg.2022.944729
McCall, Robert B; Groark, Christina J; Jappar, Akbota; Muhamedrahimov, Rifkat J; Palmov, Oleg I; Hawk, Brandi N; Chen, Abigail P; Spear, Caitlin F; Mason, Larisa
发表日期：2022
文献求助 收藏

EMBRACE: One Small Story in Lupus-One Giant Challenge in Clinical Trials

拥抱：狼疮患者面临的一个微小故事——临床试验中的巨大挑战

期刊:ACR Open Rheumatology
影响因子:2.8
doi:10.1002/acr2.11477
Sheikh, Saira Z; Englund, Tessa R; Burriss, Susan W; Bull, Jonca; Harry, Anya; Groark, James G; Hall, Ashley M; Miller, Michelle; Roth, David A
发表日期：2022
文献求助 收藏

Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol

一项针对系统性红斑狼疮 (SLE) 成人患者的皮下注射贝利木单抗联合利妥昔单抗治疗的 III 期、多中心、随机、双盲、安慰剂对照、为期 104 周的研究：BLISS-BELIEVE 研究方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2018-025687
Teng, Y K Onno; Bruce, Ian N; Diamond, Betty; Furie, Richard A; van Vollenhoven, Ronald F; Gordon, David; Groark, James; Henderson, Robert B; Oldham, Mary; Tak, Paul P
红斑狼疮
免疫/内分泌
发表日期：2019
文献求助 收藏

Development of children adopted to the United States following a social-emotional intervention in St. Petersburg (Russian Federation) institutions

在圣彼得堡（俄罗斯联邦）机构接受社会情感干预后，被美国收养的儿童的发展情况

期刊:Applied Developmental Science
影响因子:1.5
doi:10.1080/10888691.2017.1420480
Julian, Megan M; McCall, Robert B; Groark, Christina J; Muhamedrahimov, Rifkat J; Palmov, Oleg I; Nikiforova, Natasha V
发表日期：2019
文献求助 收藏

Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus

皮下注射贝利木单抗治疗抗双链DNA抗体阳性、低补体血症系统性红斑狼疮患者的疗效和安全性

期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.40511
Doria, A; Stohl, W; Schwarting, A; Okada, M; Scheinberg, M; van Vollenhoven, R; Hammer, A E; Groark, J; Bass, D; Fox, N L; Roth, D; Gordon, D
红斑狼疮
免疫/内分泌
发表日期：2018
文献求助 收藏

Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC study

系统性红斑狼疮反应指数之外的临床反应：BLISS-SC 研究的事后分析

期刊:Lupus Science & Medicine
影响因子:3.5
doi:10.1136/lupus-2018-000288
van Vollenhoven, Ronald F; Stohl, William; Furie, Richard A; Fox, Norma Lynn; Groark, James G; Bass, Damon; Kurtinecz, Milena; Pobiner, Bonnie F; Eastman, William J; Gonzalez-Rivera, Tania; Gordon, David
红斑狼疮
免疫/内分泌
发表日期：2018
文献求助 收藏